156 related articles for article (PubMed ID: 34525166)
21. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
23. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.
Rosenholm JM; Peuhu E; Eriksson JE; Sahlgren C; Lindén M
Nano Lett; 2009 Sep; 9(9):3308-11. PubMed ID: 19736973
[TBL] [Abstract][Full Text] [Related]
24. A hybrid of mPEG-b-PCL and G1-PEA dendrimer for enhancing delivery of antibiotics.
Omolo CA; Kalhapure RS; Agrawal N; Jadhav M; Rambharose S; Mocktar C; Govender T
J Control Release; 2018 Nov; 290():112-128. PubMed ID: 30312719
[TBL] [Abstract][Full Text] [Related]
25. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
Li Z; Zhang Y; Zhang K; Wu Z; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
[TBL] [Abstract][Full Text] [Related]
26. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c.
Choi E; Lim DK; Kim S
J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782
[TBL] [Abstract][Full Text] [Related]
27. Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal Nanocarrier.
Werner J; Umstätter F; Hertlein T; Mühlberg E; Beijer B; Wohlfart S; Zimmermann S; Haberkorn U; Ohlsen K; Fricker G; Mier W; Uhl P
Adv Healthc Mater; 2024 Jun; 13(14):e2303654. PubMed ID: 38387090
[TBL] [Abstract][Full Text] [Related]
28. Supramolecular amphiphiles of Beta-cyclodextrin and Oleylamine for enhancement of vancomycin delivery.
Salih M; Omolo CA; Agrawal N; Walvekar P; Waddad AY; Mocktar C; Ramdhin C; Govender T
Int J Pharm; 2020 Jan; 574():118881. PubMed ID: 31821878
[TBL] [Abstract][Full Text] [Related]
29. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
30. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
31. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
33. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
34. Modified magnetic core-shell mesoporous silica nano-formulations with encapsulated quercetin exhibit anti-amyloid and antioxidant activity.
Halevas E; Mavroidi B; Nday CM; Tang J; Smith GC; Boukos N; Litsardakis G; Pelecanou M; Salifoglou A
J Inorg Biochem; 2020 Dec; 213():111271. PubMed ID: 33069945
[TBL] [Abstract][Full Text] [Related]
35. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
Pattnaik S; Pathak K
Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
[TBL] [Abstract][Full Text] [Related]
36. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
37. Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo.
Ji N; Hong Y; Gu Z; Cheng L; Li Z; Li C
J Control Release; 2019 Nov; 313():1-13. PubMed ID: 31622690
[TBL] [Abstract][Full Text] [Related]
38. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
39. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
40. Pluronic polymer capped biocompatible mesoporous silica nanocarriers.
Yildirim A; Demirel GB; Erdem R; Senturk B; Tekinay T; Bayindir M
Chem Commun (Camb); 2013 Oct; 49(84):9782-4. PubMed ID: 24026175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
